[Table/Fig-3]:
The maternal and foetal complications in the study and the control groups.
![]() | ||
| Variable |
No. of cases in Anti TPO+ |
No. of cases in Anti TPO-ve |
| Anemia | 21 (52.5%) | 7 (17.5%) |
| Preterm delivery | 5 (12.5%) | 1 (2.5%) |
| IUGR | 6 (15%) | 8 (20%) |
| Abruption | 1 (2.5%) | 0 |
| Pre-edampsia | 4 (10%) | 2 (5%) |
| Gestational hypertension | 8 (20%) | 5 (12.5%) |
| PPH | 1 (2.5%) | 0 |
